Category: Class Action Lawsuit

Logo for The Florida Bar Foundation After years of extensive litigation, a Broward Circuit Court Judge approved a class action settlement in favor of a Class of homeowner policyholders with Defendant, Universal Property & Casualty Insurance Company (the “Insurance Company”).  

In the second verdict in the mass tort against Ethicon, Inc, a unit of Johnson & Johnson, a Philadelphia jury awarded $13.5 million in compensatory and punitive damages to the plaintiff over allegations that the company’s pelvic mesh implants are not reasonably

A Green Vision: Propelling The Environmental CrusadeEconomic growth has become the crux of our society and the has become one of the major fundamental to measure growth. Industrial growth and technological advancement has definitely boosted the world’s economy but depleted

The US Food and Drug Administration (FDA) today reclassified surgical mesh for trans-vaginal repair of pelvic organ prolapse (POP) from a moderate-risk device (class ll) to a high-risk one (class lll) and gave manufacturers 30 months to prove that their

A Delaware court has reduced a recent 100 million (25 million compensatory damages and 75 million punitive damages) verdict against Boston Scientific relating to its class action lawsuit with their trans-vaginal mesh product to 10 million (2.5 million in compensatory

The law firm of Zebersky Payne Shaw Lewenz, LLP is actively pursuing all nation-wide lawsuits against the manufacturer of the drug Invokana.  We'd like to hear your stories and give you our options.  We can be reached at 800-634-1808.  Please

Takeda, Lilly Lose Bid to Overturn $9 Billion Actos Award - Judge Will Not Overturn Actos Verdict, Takeda Still Owes $9 Billion Takeda Pharmaceutical Co. and Eli Lilly& Co. lost a bid to have a judge throw out a combined

United States Judicial Panel on Multi District Litigation established MDL No. 2545: In re: Testosterone Replacement Therapy Products Liability Litigation. The United States District Court for the Northern District of Illinois will act as the transferee court. The Panel assigned

Johnson & Johnson (JNJ) was ordered by a Texas jury to pay $1.2 million to a woman who alleged one of the company’s lines of vaginal-mesh implants to treat incontinence was defectively designed, in the first verdict against the company